Best Disease Self Management Companies in Central District, Israel
The 33 best Disease Self Management companies in Central District, Israel in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: G Medical Innovations.
Our analysis of 50 Disease Self Management companies
$3.0b in tracked funding; 94% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Disease Self Management companies in Central District
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | G Medical Innovations Provider of a suite of devices for vital signs monitoring | $41M | 36 mo ago | Public | — | 2014 | — | 164 patents Non-invasive thoracic fluid monitoring using impedance and EM sensor garments. | — |
| 2 | OrSense Provider of non-invasive sensing technology for body vitals measurement | $33M | 186 mo ago | Series B | Yoav Reisman CEO | 1996 | WordPressMySQLPHP+14 | 60 patents Non‑invasive optical blood analysis for point‑of‑care diagnostic monitoring | — |
| 3 | GluSense Implantable Glucose level sensor for Type 1 Diabetes patients | $27M | 116 mo ago | Deadpooled | — | 2007 | — | 36 patents FRET-based continuous glucose biosensing and implantable sensor cell‑culture technologies | — |
| 4 | KeePAP Provider of wearable device to monitor sleep apnea | $15M | 73 mo ago | Series C | Alex Rapoport Founder & CEO | 2012 | — | — | — |
| 5 | Kyma Remote patient monitoring solutions for chronic cardiac patients | $10M | 156 mo ago | Acqui-Hired | Uriel Weinstein Co-founder | 2008 | — | — | — |
| 6 | HeraMED Developer of remote maternity monitoring platform and related smart devices | $7M | 34 mo ago | Public | — | 2011 | WixSentryBootstrap+13 | — | — |
| 7 | Oxitone Wrist-based Pulse Oximetry health monitor | $3M | 138 mo ago | Seed | Leon Eisen Founder & Executive Chairman | 2010 | WordPressMySQLPHP+23 | — | — |
| 8 | IMMA Health Provider of ovulation stimulation monitoring system 29Talent top 38%Funding bottom 43%Global bottom 36% All 3 signals ▾Talenttop 38% Fundingbottom 43% Globalbottom 36% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $2.5M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 29/100 | $2M | 13 mo ago | Seed | Beatrice Chemla Co Founder And Ceo | 2020 | — | — | — |
| 9 | Biobeat Body vitals monitoring solution 48Tech top 34%Growth top 35%Product top 40%Funding top 46% All 7 signals ▾Techtop 34% Growthtop 35% Producttop 40% Fundingtop 46% Moattop 48% Globalbottom 38% Marketbottom 37% Tech: 38 technologies across 5/8 capability areas · Cloud: Amazon Web Services, Cloudflare Growth: Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 48/100 | $1M | 10 mo ago | Series B | — | 2014 | WordPressMySQLPHP+24 | — | — |
| 10 | Elfi-Tech Developing technology for non-invasive physiological monitoring and diagnostics | $113K | 91 mo ago | Funding Raised | Ilya Fine Founder & CEO | 2006 | — | 42 patents Non‑invasive optical blood‑pressure and hemodynamic monitoring using dynamic light scattering | — |
Top 10 Disease Self Management companies in Central District
#1
Series B · Petah Tikva, Central District · founded 2014 · 29 employees$1Mraised▾
Biobeat offers a non-invasive body vitals monitoring wearable solution. It uses reflective Pulse Oximetry technology with their algorithm to allow for constant measurements of related body vitals. Sensor delivers a range of body vitals measurement including consciousness, saturation, pulse, temperature and perspiration. The devices are connected to a mobile app or a central monitoring system where the user's data is stored. Data is then compared against a person's normal levels to identify life-threatening situations. It also allows data sharing with doctors and caregivers. They have released their products for athletes and Hospitals. Founded by Arik Ben Ishai Director of startups in the Rocket and Space Department of the Ministry of Defense, Israel.
- Dec 2025Series B$50M
- Oct 2019Grant (prize money)$188.5K
- Jun 2016Angel$1M
#2
Seed · Ra'anana, Central District · founded 2020$2.5Mraised▾
Provider of ovulation stimulation monitoring system. The company has developed an ultrasound like device for women to diagnose and monitor follicle stimulation and fertility status.
- Sep 2025Seed$2.5M
- Sep 2025Grant (prize money)—
#3
Public · Rehovot, Central District · founded 2014 · 74 employees$41.3Mraised▾
Provider of a suite of devices for vital signs monitoring. The company offers a range of consumer and Hospital grade medical devices for early detection and diagnosis of patients as well as remote monitoring. The company offers prizma G2, a smartphone case transforming any smartphone into a medical monitoring and diagnostic smartphone that captures a wide range of vital signs. The mobile application helps to collects and analyses medical data and determines correlations between tests. The company also offers – G MEDICAL PATCH (GMP), a bio-sensor monitoring system, which can be used in hospital care and post-discharge programs for continuous, real-time monitoring.
- Oct 2023Post IPO$500K
- Apr 2022Post IPO—
- Jan 2022Post IPO—
- May 2020Series B$6M
#4
Public · Netanya, Central District · founded 2011 · 21 employees$6.7Mraised▾
Developer of remote maternity monitoring platform and related smart devices. The platform offers customizable care plans, telehealth video and chat, and smart messaging. It provides remote patient monitoring, educational content, and prenatal and postpartum care. The platform aims to streamline care delivery and facilitate real-time patient health monitoring. It captures vitals, prioritizes out-of-range measurements, and manages patient adherence through a care management dashboard.
- Dec 2023Post IPO$1.2M
- Aug 2022Post IPO$4M
- Dec 2019Post IPO$1.4M
#5
Deadpooled · Lod, Central District · founded 2007 · 6 employees$26.9Mraised▾
GluSense is developing a long-term implantable continuous glucose sensor (CGM) for Type 1 Diabetes Mellitus patients. Its technology is based on a fluorescent protein which reports the level of glucose. Long term operation is achieved using engineered live cells which are encapsulated within the device and continuously produce the fluorescent protein. These genetically-engineered human cells colored red and blue move into different patterns depending on the amount of glucose in the blood. It is a portfolio company of Rainbow Medical.
- Feb 2017Series A$1.9M
- Feb 2015Series A$25M
#6
Series B · Petah Tikva, Central District · founded 1996 · 24 employees$33.2Mraised▾
Provider of non-invasive sensing technology for body vitals measurement. The company develops and commercializes patient monitoring solutions for non-invasive continuous measurements of haemoglobin, oxygen saturation, glucose, and other blood parameters. Utilizing its proprietary Occlusion Spectroscopy technology, it also enables the monitoring of the oxygen saturation of Hb (SpO2), low signal oximetry, SpO2, pulse rate, plethysmogram, and haemoglobin. The system is designed for use in hospitals in operating and recovery rooms and intensive care units as well as in outpatient sites and emergency services.
#7
Series C · Rishon Lezion, Central District · founded 2012$15.1Mraised▾
KeePAP is a provider of wearable device to monitor sleep apnea. It provides a hoseless, wearable, therapeutic positive Airway Pressure (PAP) device. Matchbox PAP unit is integrated in a soft, lightweight headgear for complete freedom of movement and uses positive airway pressure to prevent apnea events.
- Sep 2020Series C$15.1M
#8
Acqui-Hired · Kfar Saba, Central District · founded 2008 · 11 employees$10Mraised▾
Kyma Medical Technologies develops patient monitoring solutions to improve care of patients suffering from chronic cardiac illnesses. The company has developed a proprietary technology for the detection and monitoring of changes in fluid contents, based on a proprietary RF sensing technology. Kyma’s solutions aim at providing healthcare professionals with accurate information on the patient's clinical status for support of medical decision-making. Kyma’s technology is currently applied via external use, and a subcutaneous approach is under development, thus meeting the needs of a variety of patient populations. The Kyma µ-Cor is CE Mark-approved for monitoring of one or more of the following clinical parameters: Thoracic Fluid Content, ECG, heart rate, respiratory rate, activity and body posture. As of November 2016, the device is not FDA approved and still under investigation in the US.
- Oct 2013Series A$10M
#9
Seed · Kfar Saba, Central District · founded 2010 · 11 employees$3Mraised▾
Wrist-based Pulse Oximetry health monitor. It helps in remote patient monitoring using predictive and adaptive analytics. Its capabilities include detecting loss of pulse and unhealthy variations in other key vital signs, and automatically triggering an alert to emergency responders. It uses a proprietary algorithm for tracking blood oxygenation from wrist and was one of the finalists at Three Year Health Entrepreneurship Programme by GE and Startup Health in 2013.
- Apr 2015Grant (prize money)$55.1K
- Nov 2014Grant (prize money)$62.6K
- Sep 2014Seed$3M
#10
Funding Raised · Rehovot, Central District · founded 2006 · 14 employees$112.7Kraised▾
Elfi-Tech is a medical device company developing technology for non-invasive physiological monitoring and diagnostics.The Elfi mDLS sensor and signal processing tools allows continuous and non-invasive monitoring of blood flow waveform at different locations on the body. This information enables the monitoring of numerous physiological parameters such as heart rate, blood perfusion, blood pressure and different cardiac functions. Elfi-Tech collaborated with Samsung Electronics to develop this sensor module to be integrated into the Simband platform. Simband is Samsung’s wearable open platform for digital health apps. The Elfi-Tech Module measures skin blood flow, blood velocity, coagulation, vascular health and fitness assessment applications in addition to standard heart rate and motion parameters.
- Mar 2019Grant (prize money)$56.1K
- Dec 2018Grant (prize money)$56.6K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Disease Self Management coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Digital Health is moving in Israel
A read on the academic research around Digital Health — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 238 Israel-affiliated papers.
- Ben-Gurion University of the Negev36
- Hadassah Medical Center30
- Tel Aviv University30
- University of Haifa23
- Hebrew University of Jerusalem22
- Health care5
- Remote patient monitoring3
- Knowledge management2
- Vital signs2
- Scalp2
- Health care1→14
- Public health1→9
- Health care2→36
- Public health1→29
- Health services research1→22
- Health administration1→21
- Health informatics2→15
Where digital health is researched across Israel
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.